Golden David B K
Division of Allergy & Clinical Immunology, Johns Hopkins University, Baltimore, Md.
J Allergy Clin Immunol Pract. 2015 May-Jun;3(3):331-4. doi: 10.1016/j.jaip.2015.01.020. Epub 2015 Mar 25.
Large local reactions (LLRs) are IgE-mediated late-phase inflammatory reactions that can cause great morbidity but are associated with a relatively low risk of future anaphylaxis. Patients with LLR may benefit from consultation with an allergist to help clarify the relative risk, to plan the best treatment for future stings, and to determine whether or not to pursue testing or venom immunotherapy (VIT). The chance of anaphylaxis to future stings is <5%, so VIT is not generally recommended to people who have had LLR. Whether to prescribe an epinephrine injector is often determined by the frequency of exposure, the proximity to medical care, and the impact on quality of life. For people who have unavoidable exposure and need treatment almost every year for LLR, VIT can be recommended with confidence that it will significantly and safely reduce the severity of LLR to stings.
局部大反应(LLRs)是由IgE介导的迟发性炎症反应,可导致严重发病,但未来发生过敏反应的风险相对较低。发生局部大反应的患者可能会受益于咨询过敏症专科医生,以帮助明确相对风险、规划未来蜇伤的最佳治疗方案,以及确定是否进行检测或毒液免疫疗法(VIT)。未来蜇伤发生过敏反应的几率小于5%,因此一般不建议对发生过局部大反应的人进行毒液免疫疗法。是否开具肾上腺素注射器通常取决于接触频率、与医疗服务的距离以及对生活质量的影响。对于那些不可避免会接触且几乎每年因局部大反应都需要治疗的人,可以放心推荐毒液免疫疗法,因为它将显著且安全地降低蜇伤引起的局部大反应的严重程度。